A DAY WITH A BIOTECH WOMAN – AseBio
BioClonal actively participated in the second edition of the #UnDíaConUnaMujerBiotech program, an initiative promoted by the Spanish Bioindustry Association (AseBio) aimed at introducing female students to the professional world of biotechnology. This program offers future scientists the opportunity to closely observe how companies in the sector operate, promoting visibility and female talent in this key […]
IDEA AWARD
BioClonal has been awarded in the XXIX edition of the IDEA Contest, in the IDEA Project category. This is one of the oldest competitions to recognise entrepreneurial and innovative initiatives in our community and one of the oldest in the country. It is organised by the Department of Industry, Competitiveness and Business Development, through the […]
PREMIO EMPRENDE XXI – DAY INNOVATION SUMMIT CAIXABANK
Yesterday, the DayOne Innovation Summit in Aragón took place, a key event for innovative entrepreneurship in the region, organized by CaixaBank in collaboration with the Aragón Emprende Foundation. The event was part of the 17th edition of the EmprendeXXI Award, which aims to recognize the most innovative startups in each autonomous community.Among the finalists, BioClonal […]
PEGS EUROPE – Lisboa
Last November, in Lisbon, we attended #PEGSEUROPE , the 15th Annual Protein & Antibody Engineering Summit and one of the most renowned conferences in the field. BioClonal had the opportunity to explain scientific advances with the posters presentations: ➡ A003: Rational Antibody Discovery: Novel Target for Alzheimer Disease Reachable with RedMabs, presented by our Chief Executive Officer Paula Garfella➡ B025: […]
BioClonal presents RedMabs Platform & Real Biobetters at PEGS EUROPE
BioClonal introduces RedMabs Platform & Real Biobetters in PEGS Europe BioClonal will present RedMabs Platform, the company’s innovative platform to generate Real Biobetters, at the Protein & Antibody Engineering Summit (PEGS EUROPE) conference in Barcelona, Spain on November 14, 2022. Today, Paula Garfella, Business Development Manager at BioClonal, will give an oral presentation from 13:55 till 14:15 introducing BioClonal’s Therapeutics Antibody […]